Inscrição na biblioteca: Guest
Portal Digital Begell Biblioteca digital da Begell eBooks Diários Referências e Anais Coleções de pesquisa
Critical Reviews™ in Therapeutic Drug Carrier Systems
Fator do impacto: 2.9 FI de cinco anos: 3.72 SJR: 0.736 SNIP: 0.818 CiteScore™: 4.6

ISSN Imprimir: 0743-4863
ISSN On-line: 2162-660X

Volumes:
Volume 37, 2020 Volume 36, 2019 Volume 35, 2018 Volume 34, 2017 Volume 33, 2016 Volume 32, 2015 Volume 31, 2014 Volume 30, 2013 Volume 29, 2012 Volume 28, 2011 Volume 27, 2010 Volume 26, 2009 Volume 25, 2008 Volume 24, 2007 Volume 23, 2006 Volume 22, 2005 Volume 21, 2004 Volume 20, 2003 Volume 19, 2002 Volume 18, 2001 Volume 17, 2000 Volume 16, 1999 Volume 15, 1998 Volume 14, 1997 Volume 13, 1996 Volume 12, 1995

Critical Reviews™ in Therapeutic Drug Carrier Systems

DOI: 10.1615/CritRevTherDrugCarrierSyst.2017016936
pages 149-183

Supramolecular Delivery Systems for Non-Platinum Metal-Based Anticancer Drugs

Paola Ringhieri
Department of Pharmacy, Interuniversity Research Centre on Bioactive Peptides (CIRPeB), Member of CIRCMSB, University of Naples "Federico II," via Mezzocannone 16, 80134 Napoli, Italy
Giancarlo Morelli
Department of Pharmacy, Interuniversity Research Centre on Bioactive Peptides (CIRPeB), Member of CIRCMSB, University of Naples "Federico II," via Mezzocannone 16, 80134 Napoli, Italy
Antonella Accardo
Department of Pharmacy, Interuniversity Research Centre on Bioactive Peptides (CIRPeB), Member of CIRCMSB, University of Naples "Federico II," via Mezzocannone 16, 80134 Napoli, Italy

RESUMO

Stimulated by the enormous success of the inorganic complex cisplatin in tumor treatment, interest in metal complexes has recently grown. Within cells, metal complexes can participate in reactions that are not possible with conventional organic substances, and most of them have promising efficacy as anticancer drugs. However, to be effective in vivo metal complexes need adequate delivery systems able to increase their water solubility, the in vivo bioavailability, and the safe delivery to target organs. The present review reports on the state of the art of these new, nonplatinum, anticancer metallodrugs delivered by nanosized vehicles. The development of complexes of ruthenium, gold, cobalt, copper, gallium, and others that show promising antitumor efficacy is reported, and we emphasize the different approaches in the individuation of the most appropriate delivery system for each of them.


Articles with similar content:

Combination Cancer Therapy Using Multifunctional Liposomes
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.37, 2020, issue 2
Ankita Tiwari, Shivani Saraf, Amit Verma, Ankit Jain, Sanjay Kumar Jain
Pharmaceutical Cocrystals: A Novel Approach for Oral Bioavailability Enhancement of Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.29, 2012, issue 3
Renu Chadha, Poonam Arora, Swati Bhandari, Anupam Saini
Peptide and Protein Delivery Using New Drug Delivery Systems
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.30, 2013, issue 4
Ashish Jain, Satish Shilpi, Pooja Hurkat, Aviral Jain, Arvind Gulbake, Sanjay Kumar Jain
Polymeric Lipid Hybrid Nanoparticles: Properties and Therapeutic Applications
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.35, 2018, issue 6
Kesrin Amra, Munira Momin, Chintan Bhavsar, Abdelwahab Omri, Cyril Jose
Oral Colon-Specific Drug Delivery of Protein and Peptide Drugs
Critical Reviews™ in Therapeutic Drug Carrier Systems, Vol.24, 2007, issue 1
Ruchita V. Kumar, Sanjay Singh, Vivek Ranjan Sinha, J. R. Bhinge, Asmita Singh, Rachana Kumria